PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149254
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149254
Fusion Biopsy Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of fusion biopsy Market
The global fusion biopsy market size was valued at USD 793.5 million in 2025 and is projected to grow from USD 852.1 million in 2026 to USD 1,546.7 million by 2034, exhibiting a CAGR of 7.7% during the forecast period. North America dominated the global fusion biopsy market with a 34.04% share in 2025, supported by advanced healthcare infrastructure, increasing prostate cancer diagnosis, and growing adoption of MRI-ultrasound fusion technologies.
Fusion biopsy combines MRI and ultrasound imaging to create detailed, real-time images of the prostate and guide biopsy needles toward suspicious lesions. Increasing demand for accurate and minimally invasive prostate cancer diagnosis is supporting market growth. Leading companies are focusing on AI-enabled imaging, automated workflows, robotic systems, and strategic collaborations to improve diagnostic precision and expand market presence.
MARKET KEY TAKEAWAYS
The global fusion biopsy market is expected to increase from USD 793.5 million in 2025 to USD 852.1 million in 2026 and reach USD 1,546.7 million by 2034, registering a 7.7% CAGR. North America held a 34.04% market share in 2025. The transperineal segment is projected to grow at a 7.9% CAGR, while diagnostic centers are expected to grow at an 8.0% CAGR.
MARKET DYNAMICS
MARKET DRIVERS
Rising Incidence of Prostate Cancer
The increasing incidence of prostate cancer is driving demand for early, accurate, and minimally invasive diagnostic procedures. Fusion biopsy enables improved lesion localization and targeted tissue sampling compared with conventional approaches, encouraging adoption across hospitals and healthcare facilities.
MARKET RESTRAINTS
High Capital Investment
MRI-ultrasound fusion systems require significant investment in imaging equipment, specialized software, and compatible ultrasound platforms. High costs can restrict adoption in resource-limited healthcare facilities, where conventional transrectal ultrasound biopsy remains a lower-cost alternative.
MARKET OPPORTUNITIES
Expansion in Emerging Markets
Healthcare infrastructure expansion across Asia Pacific and Latin America is creating opportunities for fusion biopsy manufacturers. Increasing medical tourism in countries such as India, Brazil, China, and South Korea, combined with greater access to advanced diagnostics, can support future adoption.
MARKET TRENDS
Increasing Adoption of AI-Enhanced Fusion Biopsy Platforms
AI is increasingly being incorporated into multiparametric MRI analysis, lesion detection, PI-RADS scoring assistance, automated reporting, and real-time 3D mapping. In September 2024, KOELIS partnered with DeepHealth to integrate AI-powered prostate MRI interpretation into its Trinity 3D ultrasound platform.
MARKET CHALLENGES
Limited Availability of Trained Professionals
Fusion biopsy requires specialized expertise in multiparametric MRI interpretation and targeted biopsy procedures. Differences in clinical expertise, limited numbers of trained professionals, and workflow integration challenges between radiology and urology departments can restrict adoption.
SEGMENTATION ANALYSIS
By Product
The market is segmented into equipment and consumables. Equipment accounted for the largest share in 2025, supported by increasing installation of fusion biopsy systems. The consumables segment is projected to grow at a 7.8% CAGR.
By Procedure
The market is divided into transrectal and transperineal procedures. Transrectal biopsy dominated in 2025 due to its established clinical workflow and lower procedural complexity, and is expected to hold 74.8% in 2026. Transperineal biopsy is projected to grow at a 7.9% CAGR.
By End User
Hospitals, diagnostic centers, and others constitute the major end-user segments. Hospitals dominated in 2025 and are expected to hold 54.4% in 2026, supported by advanced imaging infrastructure and higher patient volumes. Diagnostic centers are projected to grow at an 8.0% CAGR.
REGIONAL OUTLOOK
North America
North America remained the leading region, reaching USD 270.1 million in 2025. The U.S. market is estimated to reach USD 261.6 million in 2026, supported by established healthcare infrastructure and increasing use of MRI before prostate biopsy.
Europe
Europe is projected to reach USD 250.8 million in 2026, with a 7.7% growth rate. The U.K., Germany, and France are estimated at USD 52.2 million, USD 59.9 million, and USD 44.9 million, respectively, in 2026.
Asia Pacific
Asia Pacific is expected to reach USD 223.2 million in 2026. China and India are estimated at USD 33.6 million and USD 66.6 million, respectively.
Latin America and Middle East & Africa
Latin America is projected to reach USD 57.8 million in 2026, while the GCC is expected to reach USD 17.9 million.
COMPETITIVE LANDSCAPE
Key companies include GE HealthCare, KOELIS, Koninklijke Philips N.V., BiopSee, Focal Healthcare, Exact Imaging, Biobot Surgical, UC-Care Medical Systems, and Eigen Health. Companies are focusing on AI integration, product development, regulatory approvals, partnerships, and expansion into emerging markets.
KEY INDUSTRY DEVELOPMENTS
In January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system received CE certification for prostate biopsy and ablation. In March 2024, GE HealthCare introduced its AI-enabled Prostate Volume Assist feature. FUJIFILM launched the ARIETTA 65 IntuitiveFusion system in Japan in April 2023, while KOELIS introduced additional biopsy and MRI-processing technologies in February 2022.
REPORT COVERAGE
The report covers the global fusion biopsy market across product, procedure, and end-user segments. It includes market dynamics, regional analysis, competitive landscape, market opportunities, challenges, trends, product launches, regulatory developments, partnerships, and strategic initiatives undertaken by key market participants.
CONCLUSION
The global fusion biopsy market is projected to grow from USD 793.5 million in 2025 to USD 852.1 million in 2026 and USD 1,546.7 million by 2034, at a 7.7% CAGR. Rising prostate cancer incidence, increasing demand for precise diagnosis, AI-enhanced imaging, and expansion of healthcare infrastructure are expected to support market growth. However, high equipment costs, specialized training requirements, and workflow integration challenges remain important considerations for wider adoption.
Segmentation By Product
- Equipment
- Consumables
By Procedure
- Transrectal
- Transperineal
By End-user
- Hospitals
- Diagnostic Centers
- Others
By Geography
- North America (By Product, Procedure, End-user, and Country)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, Procedure, End-user, and Country/Sub-region)
- Germany (By Product)
- U.K. (By Product)
- France (By Product)
- Spain (By Product)
- Italy (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, Procedure, End-user, and Country/Sub-region)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Size, Procedure, End-user, and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, Procedure, End-user, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
- Rest of the Middle East & Africa (By Product)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2025
- 4.2. New Product Launches, By Key Players
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.4. Technological Advancements in Fusion Biopsy Systems
5. Global Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Equipment
- 5.1.2. Consumables
- 5.2. Market Analysis, Insights and Forecast - By Procedure
- 5.2.1. Transrectal
- 5.2.2. Transperineal
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals
- 5.3.2. Diagnostic Centers
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Equipment
- 6.1.2. Consumables
- 6.2. Market Analysis, Insights and Forecast - By Procedure
- 6.2.1. Transrectal
- 6.2.2. Transperineal
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals
- 6.3.2. Diagnostic Centers
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 6.4.1. U.S.
7. Europe Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Equipment
- 7.1.2. Consumables
- 7.2. Market Analysis, Insights and Forecast - By Procedure
- 7.2.1. Transrectal
- 7.2.2. Transperineal
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals
- 7.3.2. Diagnostic Centers
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Product
- 7.4.2. Germany
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Spain
- 7.4.4.1. By Product
- 7.4.5. Italy
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 7.4.1. U.K.
8. Asia Pacific Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Equipment
- 8.1.2. Consumables
- 8.2. Market Analysis, Insights and Forecast - By Procedure
- 8.2.1. Transrectal
- 8.2.2. Transperineal
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Centers
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Product
- 8.4.2. China
- 8.4.2.1. By Product
- 8.4.3. Australia
- 8.4.3.1. By Product
- 8.4.4. India
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 8.4.1. Japan
9. Latin America Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Equipment
- 9.1.2. Consumables
- 9.2. Market Analysis, Insights and Forecast - By Procedure
- 9.2.1. Transrectal
- 9.2.2. Transperineal
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals
- 9.3.2. Diagnostic Centers
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 9.4.1. Brazil
10. Middle East & Africa Fusion Biopsy Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Equipment
- 10.1.2. Consumables
- 10.2. Market Analysis, Insights and Forecast - By Procedure
- 10.2.1. Transrectal
- 10.2.2. Transperineal
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals
- 10.3.2. Diagnostic Centers
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Product
- 10.4.2. GCC
- 10.4.2.1. By Product
- 10.4.3. Rest of Latin America
- 10.4.3.1. By Product
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. KOELIS
- 11.2.2. Koninklijke Philips N.V
- 11.2.3. BiopSee
- 11.2.4. Focal Healthcare
- 11.2.5. GE HealthCare
- 11.2.6. Exact imaging
- 11.2.7. Biobot Surgical
- 11.2.8. UC-Care Medical Systems
- 11.2.9. Eigen Health
List of Tables
- Table 1: Global Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 2: Global Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 3: Global Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 4: Global Fusion Biopsy Market Revenue (USD million) Forecast, by Region, 2021-2034
- Table 5: North America Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 6: North America Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 7: North America Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 8: North America Fusion Biopsy Market Revenue (USD million) Forecast, By Country, 2021-2034
- Table 9: U.S. Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 10: Canada Fusion Biopsy Market Revenue (USD million) Forecast, By Product, 2021-2034
- Table 11: Europe Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 12: Europe Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 13: Europe Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 14: Europe Fusion Biopsy Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: Germany Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 16: U.K. Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 17: France Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 18: Italy Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 19: Spain Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 20: Scandinavia Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 21: Rest of Europe Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 22: Asia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 23: Asia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 24: Asia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 25: Asia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: China Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 27: India Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 28: Japan Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 29: Australia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 30: Southeast Asia Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 31: Rest of Asia Pacific Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 32: Latin America Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 33: Latin America Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 34: Latin America Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 35: Latin America Fusion Biopsy Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Brazil Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 37: Mexico Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 38: Rest of Latin America Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 39: Middle East & Africa Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 40: Middle East & Africa Fusion Biopsy Market Revenue (USD million) Forecast, by Procedure, 2021-2034
- Table 41: Middle East & Africa Fusion Biopsy Market Revenue (USD million) Forecast, by End-user 2021-2034
- Table 42: Middle East & Africa Fusion Biopsy Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 43: GCC Fusion Biopsy Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 44: South Africa Fusion Biopsy Market Revenue (USD million) Forecast, By Product, 2021-2034
- Table 45: Rest of Middle East & Africa Fusion Biopsy Market Revenue (USD million) Forecast, By Product, 2021-2034
List of Figures
- Figure 1: Global Fusion Biopsy Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
- Figure 2: Global Fusion Biopsy Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Fusion Biopsy Market Value Share (%), by Procedure, 2025 & 2034
- Figure 4: Global Fusion Biopsy Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Fusion Biopsy Market Value (USD million), by Region, 2025 & 2034
- Figure 6: North America Fusion Biopsy Market Value (USD million), by Product, 2025 & 2034
- Figure 7: North America Fusion Biopsy Market Value Share (%), by Product, 2025
- Figure 8: North America Fusion Biopsy Market Value (USD million), by Procedure, 2025 & 2034
- Figure 9: North America Fusion Biopsy Market Value Share (%), by Procedure, 2025
- Figure 10: North America Fusion Biopsy Market Value (USD million), by End-user, 2025 & 2034
- Figure 11: North America Fusion Biopsy Market Value Share (%), by End-user, 2025
- Figure 12: North America Fusion Biopsy Market Value (USD million), By Country, 2025 & 2034
- Figure 13: North America Fusion Biopsy Market Value Share (%), By Country, 2025
- Figure 14: Europe Fusion Biopsy Market Value (USD million), by Product, 2025 & 2034
- Figure 15: Europe Fusion Biopsy Market Value Share (%), by Product, 2025
- Figure 16: Europe Fusion Biopsy Market Value (USD million), by Procedure, 2025 & 2034
- Figure 17: Europe Fusion Biopsy Market Value Share (%), by Procedure, 2025
- Figure 18: Europe Fusion Biopsy Market Value (USD million), by End-user, 2025 & 2034
- Figure 19: Europe Fusion Biopsy Market Value Share (%), by End-user, 2025
- Figure 20: Europe Fusion Biopsy Market Value (USD million), By Country/Sub-region, 2025 & 2034
- Figure 21: Europe Fusion Biopsy Market Value Share (%), By Country/Sub-region, 2025
- Figure 22: Asia Pacific Fusion Biopsy Market Value (USD million), by Product, 2025 & 2034
- Figure 23: Asia Pacific Fusion Biopsy Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Fusion Biopsy Market Value (USD million), by Procedure, 2025 & 2034
- Figure 25: Asia Pacific Fusion Biopsy Market Value Share (%), by Procedure, 2025
- Figure 26: Asia Pacific Fusion Biopsy Market Value (USD million), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Fusion Biopsy Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Fusion Biopsy Market Value (USD million), By Country/Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Fusion Biopsy Market Value Share (%), By Country/Sub-region, 2025
- Figure 30: Latin America Fusion Biopsy Market Value (USD million), by Product, 2025 & 2034
- Figure 31: Latin America Fusion Biopsy Market Value Share (%), by Product, 2025
- Figure 32: Latin America Fusion Biopsy Market Value (USD million), by Procedure, 2025 & 2034
- Figure 33: Latin America Fusion Biopsy Market Value Share (%), by Procedure, 2025
- Figure 34: Latin America Fusion Biopsy Market Value (USD million), by End-user, 2025 & 2034
- Figure 35: Latin America Fusion Biopsy Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Fusion Biopsy Market Value (USD million), By Country/Sub-region, 2025 & 2034
- Figure 37: Latin America Fusion Biopsy Market Value Share (%), By Country/Sub-region, 2025
- Figure 38: Middle East & Africa Fusion Biopsy Market Value (USD million), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Fusion Biopsy Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Fusion Biopsy Market Value (USD million), by Procedure, 2025 & 2034
- Figure 41: Middle East & Africa Fusion Biopsy Market Value Share (%), by Procedure, 2025
- Figure 42: Middle East & Africa Fusion Biopsy Market Value (USD million), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Fusion Biopsy Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Fusion Biopsy Market Value (USD million), By Country/Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Fusion Biopsy Market Value Share (%), By Country/Sub-region, 2025
- Figure 46: Global Fusion Biopsy Market Share (%), By Company, 2025
